National Gay Men's HIV/AIDS Awareness Day
National Gay Men's HIV/AIDS Awareness Day brings attention to the heavy impact of HIV/AIDS on gay and bisexual men, particularly African American men.
Event updated 01/18/2024
National Gay Men's HIV/AIDS Awareness Day brings attention to the heavy impact of HIV/AIDS on gay and bisexual men, particularly African American men.
Event updated 01/18/2024
Event updated 01/18/2024
Resource updated 08/28/2023
Series of webinars for Ryan White HIV/AIDS Program (RWHAP) agencies, by HRSA's HIV/AIDS Bureau.
Resource updated 03/07/2024
Webinars and other special events by HRSA's HIV/AIDS Bureau.
Resource updated 01/09/2024
Blog updated 01/07/2021
People may be able to get or stay covered with Marketplace/off-Marketplace health insurance through a Special Enrollment Period.
Blog updated 01/29/2024
In response to clinic operation curtailments during COVID-19 lockdowns, telehealth services have expanded across the nation.
Blog updated 01/17/2023
Resource updated 09/19/2023
Resource updated 03/15/2023
Blog updated 08/12/2022
Staff will present a population-based, data-driven approach to the Minority AIDS Initiative (MAI) funding designed to improve program engagement and retention to reduce health disparities and maximize health outcomes. Presenters will review methods to facilitate replication of the model in other Ryan White programs.
Resource (Conference Presentation) updated 09/14/2023
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
The Marketplace Open Enrollment period lasts only six weeks in most states, and RWHAP programs face challenges in ensuring eligible clients are enrolled or renew their coverage. Participants will gain new strategies for creating effective enrollment partnerships as well as how to prepare staff, partners, and clients for Open Enrollment.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023
Rapid initiation of antiretroviral therapy (ART) after diagnosis can increase the number of patients arriving for appointments, shorten time to viral suppression, and promote health equity. The presenters share key lessons learned through the implementation process at a large HIV clinic in the South with the theme of partnerships.
Resource (Conference Presentation) updated 09/14/2023
In December 2016 CrescentCare began linking individuals newly diagnosed with within 72-hours through the CrescentCare START Initiative. We compared linkage and viral suppression between those under and over 24 years old. We found similar successful outcomes for both age cohorts in our intervention.
Resource (Conference Presentation) updated 09/14/2023